Richard H Wiggins

Dr. Richard H Wiggins

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2001 in RadioGraphics
Verified
Journal Article
Closed access
RWRichard H Wiggins
Richard H Wiggins
HDH. Christian Davidson
H. Christian Davidson
HHH. Ric Harnsberger
H. Ric Harnsberger
JLJason R. Lauman
Jason R. Lauman
PGPatricia A. Goede
Patricia A. Goede
Despite the rapid growth of the Internet for storage and display of World Wide Web-based teaching files, the available image file formats have remained relatively limited. The recently developed portable networks graphics (PNG) format is versatile and offers several advantages over the older Internet standard image file formats that make it an attractive option for digital teaching files. With the PNG format, it is possible to repeatedly open, edit, and save files with lossless compression along with gamma and chromicity correction. The two-dimensional interlacing capabilities of PNG allow an image to fill in from top to bottom and from right to left, making retrieval faster than with other formats. In addition, images can be viewed closer to the original settings, and metadata (ie, information about data) can be incorporated into files. The PNG format provides a network-friendly, patent-free, lossless compression scheme that is truly cross-platform and has many new features that are useful for multimedia and Web-based radiologic teaching. The widespread acceptance of PNG by the World Wide Web Consortium and by the most popular Web browsers and graphic manipulation software companies suggests an expanding role in the future of multimedia teaching file development.

1 January 2015 in Radiologic Clinics of North America
Verified
Journal Article
Closed access
LELaura B. Eisenmenger
Laura B. Eisenmenger
RWRichard H Wiggins
Richard H Wiggins

1 September 2006
Verified
Journal Article
Closed access
AMA.K. Morimoto
A.K. Morimoto
RWRichard H Wiggins
Richard H Wiggins
PHP.A. Hudgins
P.A. Hudgins
GHG.L. Hedlund
G.L. Hedlund
BHB. Hamilton
B. Hamilton
HHH.R. Harnsberger
H.R. Harnsberger

11 February 2016 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
KCK.M. Chevallier
K.M. Chevallier
RWRichard H Wiggins
Richard H Wiggins
NQN.A. Quinn
N.A. Quinn
RGR.K. Gurgel
R.K. Gurgel
BACKGROUND AND PURPOSE: Rhabdomyosarcoma and Langerhans cell histiocytosis are malignant lesions that can affect the skull base with similar radiographic characteristics on CT and MR imaging. We hypothesized that location within the temporal bone determined radiographically can provide useful adjunctive information in differentiating these distinct neoplasms. MATERIALS AND METHODS: We identified patients with Langerhans cell histiocytosis and rhabdomyosarcoma by using an imaging data base and International Classification of Diseases, Ninth Revision codes at a tertiary care academic medical center. Cross-sectional images were reviewed by a neurotologist and neuroradiologist, who evaluated the location of the lesions and scored each subsite—middle ear, mastoid, petrous apex, retrosigmoid/posterior fossa—on a scale of 0 (no involvement), 1 (partial), or 2 (complete involvement). RESULTS: We identified 12 patients representing 14 cases of Langerhans cell histiocytosis, and 9 patients representing 9 cases of rhabdomyosarcoma. For patients with Langerhans cell histiocytosis, mastoid involvement was rated 23/28 (82%) compared with 6/18 (33%) with rhabdomyosarcoma (P = .001). Langerhans cell histiocytosis was present in only the anterior portion of the temporal bone (petrous apex and middle ear) in 1 case (7.1%) and in the anterior portion of the temporal bone only in 5/9 (55%) cases of rhabdomyosarcoma (P = .018). The cortical bone was more commonly involved in Langerhans cell histiocytosis, 11/28 (39%) of cases compared with 2/18 (11%) cases in rhabdomyosarcoma (P <.05). CONCLUSIONS: These results indicate that lesions involving only the anterior portion of the temporal bone (petrous apex and middle ear) are more likely to be rhabdomyosarcoma. Lesions involving the mastoid are more likely to be Langerhans cell histiocytosis. This difference in primary location may be helpful in predicting the pathology of these lesions on the basis of imaging.

27 May 2022 in Cancers
Verified
Journal Article
Open access
PDF file
BKBhasker rao Koppula
Bhasker rao Koppula
GFGabriel Fine
Gabriel Fine
ASAhmed Ebada Salem
Ahmed Ebada Salem
MCMatthew F. Covington
Matthew F. Covington
RWRichard H Wiggins
Richard H Wiggins
KMKathryn Ann Morton
Kathryn Ann Morton
PET-CT is an advanced imaging modality with many oncologic applications, including staging, assessment of response to therapy, restaging and longitudinal surveillance for recurrence. The goal of this series of six review articles is to provide practical information to providers and imaging professionals regarding the best use of PET-CT for specific oncologic indications, and the potential pitfalls and nuances that characterize these applications. In the third of these review articles, key tumor-specific clinical information and representative PET-CT images are provided to outline the role that PET-CT plays in the management of patients with gastrointestinal malignancies. The focus is on the use of 18F fluorodeoxyglucose (FDG), rather than on research radiopharmaceuticals under development. Many different types of gastrointestinal tumors exist, both pediatric and adult. A discussion of the role of FDG PET-CT for all of these is beyond the scope of this review. Rather, this article focuses on the most common adult gastrointestinal malignancies that may be encountered in clinical practice. The information provided here will provide information outlining the appropriate role of PET-CT in the clinical management of patients with gastrointestinal malignancies for healthcare professionals caring for adult cancer patients. It also addresses the nuances and provides interpretive guidance related to PET-CT for imaging providers, including radiologists, nuclear medicine physicians and their trainees.

1 January 2015 in Radiologic Clinics of North America
Verified
Journal Article
Closed access
TATravis A. Abele
Travis A. Abele
RWRichard H Wiggins
Richard H Wiggins